Portfolio Podcast | Why India-focussed pharma stocks are a safer bet
Portfolio Podcast | Why India-focussed pharma stocks are a safer bet
Sai Prabhakar and Parv Shah discuss the reasons why a tilt to Indian generics can be rewarding
Sai Prabhakar and Parv Shah discuss the reasons why a tilt to Indian generics can be rewarding